Strongly enhanced toxicity of the mushroom toxin alpha-amanitin by an amatoxin-specific Fab or monoclonal antibody.
H Faulstich, K Kirchner, M Derenzini
Index: Toxicon 26(5) , 491-9, (1988)
Full Text: HTML
Abstract
A monoclonal antibody, with high affinity against the mushroom toxin alpha-amanitin, was prepared. Administration of the Fab fragment of the monoclonal antibody to mice caused a 50-fold increase in alpha-amanitin toxicity. Electron micrographs showed normal appearance of hepatocytes but typical, amanitin-induced lesions in cells of the proximal convoluted tubules of the kidney. The pronounced nephrotoxicity is mainly explained by glomerular filtration and tubular reabsorption of the Fab-amatoxin complex and, to a lesser extent, of the immunoglobulin-amatoxin complex, which is still c. Twice as toxic as free alpha-amanitin. To our knowledge this is the first reported case where immunoglobulins or their fragments enhance rather than decrease the activity of a toxin. Accordingly, immunotherapy of Amanita mushroom poisoning in humans does not appear promising.
Related Compounds
Related Articles:
2003-10-01
[Chudoku. Kenkyu. 16(4) , 441-5, (2003)]
1997-02-07
[J. Chromatogr. B. Biomed. Sci. Appl. 689(1) , 81-9, (1997)]
2000-10-01
[J. Chromatogr. B. Biomed. Sci. Appl. 748(1) , 125-35, (2000)]
1985-08-15
[Anal. Biochem. 149(1) , 35-42, (1985)]
2008-08-05
[J. Pharm. Biomed. Anal. 47(4-5) , 913-7, (2008)]